Pricing and Reimbursement Analysis of Bacillus Calmette-Guérin (BCG) Immunotherapy for Bladder Cancer
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2385
https://www.valueinhealthjournal.com/article/S1098-3015(14)04315-0/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1840
First Page :
A654
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04315-0&doi=10.1016/j.jval.2014.08.2385